Weight-loss drug Ozempic could increase risk of sight loss
The weight-loss drug Ozempic could increase the risk of vision loss, a new study found. Ozempic has been hailed as a ...
Zacks.com on MSN3d
NVO to Invest $1.2B in New Rare Disease Drugs Facility in Denmark
Novo Nordisk is set to invest $1.2 billion for a new facility in Odense, Denmark, to produce various product types for rare ...
Healthline5d
Ozempic Dosage
Ozempic (semaglutide) is prescribed for adults with type 2 diabetes. The drug is given as an injection under the skin once per week. Doctors usually prescribe a starting dose and a maintenance dose.
Novo Nordisk invests $1.2 bln in new rare disease drugs plant in Denmark
Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the ...
I Took a GLP-1 Medication for 5 Months—Here’s Why I Stopped
A UCLA student is suing multiple California health care providers and hospitals for medical negligence, alleging she was ...
Yahoo19h
An experimental drug drove people to lose 23% of their body weight. It’s still seen as a disappointment
Novo Nordisk CEO Lars Fruergaard Joergensen in December during a presentation of a new production site. The company's latest ...
GlobalData on MSN3d
Novo Nordisk invests $1.2bn in new Denmark facility
Construction has already begun on the Ozempic-producer’s new Danish production facility and 40,000m² warehouse.
What did Irish Times readers search for most in 2024?
Irish aircraft leasing giant AerCap experienced a cybersecurity attack on its systems, causing claims to circulate online ...
MM&M4d
Novo Holdings’ $16.5B deal for Catalent clears last regulatory hurdle
As part of the agreement, Catalent will sell the three sites to Novo for $11 billion. The factories in Italy, Belgium and the ...